Previous 10 | Next 10 |
home / stock / jnj / jnj articles
Amid the ongoing scrutiny from Congress, WuXi AppTec and its affiliates face another setback as the Biotechnology Innovation Organization...
Bayer AG (OTC:BAYRY) (OTC:BAYZF) is reportedly considering utilizing the Texas Two-Step bankruptcy approach to tackle the onslaught of lawsuit...
On Friday, 15 March, the FDA’s Oncologic Drugs Advisory Committee will meet to discuss Johnson & Johnson (NYSE:JNJ) / ...
Morgan Stanley initiates Arcellx Inc (NASDAQ:ACLX), noting a differentiated CAR-T platform for blood cancer backed by an established...
In a move outlined in his upcoming State of the Union address, President Joe Biden is pushing for an increase in the number of prescripti...
As President Joe Biden prepares for his State of the Union address on Thursday, he's expected to touch on several key issues including Bidenom...
In today's fast-paced and highly competitive business world, it is crucial for investors and industry followers to conduct comprehensive compa...
Tuesday, the FDA approved Johnson & Johnson’s (NYSE:JNJ) supplemental Biologics License Application for Tecvayli (teclistamab-c...
Thursday, Illumina Inc (NASDAQ:ILMN) reported fourth-quarter 2023 sales of $1.12 billion, up 4% Y/Y, beating the consensus of $1.09 ...
News, Short Squeeze, Breakout and More Instantly...
Johnson & Johnson seeks U.S. FDA approval of SPRAVATO® (esketamine) as the first and only monotherapy for adults with treatment-resistant depression Johnson & Johnson seeks U.S. FDA approval of SPRAVATO® (esketamine) as the first and only monotherapy for adults with tr...
2024-07-18 11:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 05:40:00 ET On July 17, Johnson & Johnson (NYSE: JNJ) announced second-quarter results that gave investors a lot to look forward to. Integration of newly acquired medical technology plus upcoming expansions of patent-protected medicines will help push the healthcare c...